Loading
US
Community
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. Please do your own research before investing.

TrustFinance Global Insights
8月 26, 2026
1 min read
0

Boston Scientific (BSX) reported a cybersecurity incident on August 25, disrupting global operations, including systems for customer order processing and shipping. The medical device maker's shares fell approximately 4% following the announcement. This incident highlights ongoing cyber vulnerabilities across the healthcare sector.
The company immediately activated response procedures with third-party specialists. While recovery efforts are underway, the attack is expected to continue affecting parts of its business. Evercore ISI analyst Vijay Kumar suggested a potential 600-700 basis-point impact on Boston Scientific’s Q3 revenue, based on similar past incidents in the sector.
Boston Scientific has not yet determined if the incident will have a material business impact. The investigation is ongoing to ascertain the full scope and nature of the breach. This event underscores persistent cybersecurity challenges for major healthcare firms.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles